Patients available for hyperprogressive disease analysis(n=99)
Without measurable lesions (n=50)Laboratory test results not available (n=1)
Patients pathologically confirmed BTC（n=704）
Patients treated with ICIs(n=150)
Treated with other agent (n= 56)
Patients with appropriate radiological evaluations（n=206)
Without appropriate radiological evaluations
